Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Gacci

Showing results (1-10 of 253) with videos related to

Pageof 26
Sort By:
The Journal of Urology|July 12, 2014
Editorial commentMauro Gacci
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2012
Editorial comment to postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomyMauro Gacci
International Journal of Urology : Official Journal of the Japanese Urological Association|September 11, 2012
Editorial Comment to tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian menMauro Gacci
The Journal of Urology|December 19, 2012
Editorial commentMauro Gacci
Urologia Internationalis|May 28, 2014
Editorial comment on Zhang et al.: Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese menMauro Gacci
The Journal of Urology|September 28, 2020
Editorial CommentMauro Gacci, Luca Gemma
European Urology Focus|April 1, 2018
Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract SymptomsArcangelo Sebastianelli, Mauro Gacci
European Urology|May 20, 2008
Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44Mauro Gacci, Marco Carini, Mario Maggi
Nature Reviews. Urology|January 13, 2016
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndromeLinda Vignozzi, Mauro Gacci, Mario Maggi
Prostate Cancer and Prostatic Diseases|December 1, 2023
Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progressionMauro Gacci, Pantelis Makrides, Pietro Spatafora
Pageof 26

Showing results (1-10 of 253) with videos related to

Sort By:
Pageof 26
The Journal of Urology|July 12, 2014
Editorial commentMauro Gacci
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2012
Editorial comment to postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomyMauro Gacci
International Journal of Urology : Official Journal of the Japanese Urological Association|September 11, 2012
Editorial Comment to tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian menMauro Gacci
The Journal of Urology|December 19, 2012
Editorial commentMauro Gacci
Urologia Internationalis|May 28, 2014
Editorial comment on Zhang et al.: Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese menMauro Gacci
The Journal of Urology|September 28, 2020
Editorial CommentMauro Gacci, Luca Gemma
European Urology Focus|April 1, 2018
Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract SymptomsArcangelo Sebastianelli, Mauro Gacci
European Urology|May 20, 2008
Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44Mauro Gacci, Marco Carini, Mario Maggi
Nature Reviews. Urology|January 13, 2016
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndromeLinda Vignozzi, Mauro Gacci, Mario Maggi
Prostate Cancer and Prostatic Diseases|December 1, 2023
Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progressionMauro Gacci, Pantelis Makrides, Pietro Spatafora
Pageof 26